Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis

European Journal of Neurology

Volumn 20, Issue 9, 2013, Pages 1272-1276

  Nakata, R ^a   Motomura, M ^a   Masuda, T ^a   Shiraishi, H ^a   Tokuda, M ^a   Fukuda, T ^a   Ando, T ^a   Yoshimura, T ^a   Tsujihata, M ^a,b   Kawakami, A ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Nagasaki Kita Hospital   (Japan)

Author keywords

Associated autoimmune disease; Muscle specific receptor tyrosine kinase; Myasthenia gravis; Thymus; Titin antibodies

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; ENZYME ANTIBODY; MUSCLE SPECIFIC RECEPTOR TYROSINE KINASE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THYMOMA; THYMUS;

ASSOCIATED AUTOIMMUNE DISEASE; MUSCLE-SPECIFIC RECEPTOR TYROSINE KINASE; MYASTHENIA GRAVIS; THYMUS; TITIN ANTIBODIES;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CONNECTIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RADIOIMMUNOASSAY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; THYMOMA; THYMUS GLAND; THYMUS HYPERPLASIA; THYMUS NEOPLASMS;

EID: 84881027361     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12169     Document Type: Article

References (43)

1. Lang B, Vincent A. Autoimmune disorders of the neuromuscular junction. Curr Opin Pharmacol 2009; 9: 336-340.
2. Leite MI, Waters P, Vincent A. Diagnostic use of autoantibodies in myasthenia gravis. Autoimmunity 2010; 43: 371-379.
3. Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001; 7: 365-368.
4. Higuchi O, Hamuro J, Motomura M, et al. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 2011; 69: 418-422.
5. Skeie GO, Romi F. Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol 2008; 15: 1029-1033.
6. Evoli A, Minisci C, Di Schino C, et al. Thymoma in patients with MG: characteristics and long-term outcome. Neurology 2002; 59: 1844-1850.
7. Murai H, Yamashita N, Watanabe M, et al. Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey. J Neurol Sci 2011; 305: 97-102.
8. Meriggioli MN, Sanders D. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009; 8: 475-490.
9. Aarli JA. Myasthenia gravis in the elderly: is it different? Ann N Y Acad Sci 2008; 1132: 238-243.
10. Suzuki S, Utsugisawa K, Nagane Y, et al. Clinical and immunological differences between early and late-onset myasthenia gravis in Japan. J Neuroimmunol 2011; 230: 148-152.
11. Leite MI, Jones M, Ströbel P, et al. Myasthenia gravis thymus. Am J Pathol 2007; 171: 893-905.
12. Schluep M, Willcox N, Vincent A, et al. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistochemical study. Ann Neurol 1987; 22: 212-222.
13. Oosterhuis HJG. Myasthenia gravis. Clin Neurol Neurosurg 1981; 83: 105-135.
14. Tola MR, Caniatti LM, Granieri E, et al. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy. Acta Neurol Scand 1994; 90: 318-323.
15. Christensen PB, Jensen TS, Tsiropoulos I, et al. Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol Scand 1995; 91: 192-195.
16. Guptill J, Sanders D. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis. Curr Opin Neurol 2010; 21: 530-535.
17. Sanders DB, El-Salem K, Massey JM, et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003; 60: 1978-1980.
18. Zhou L, McConville J, Chaudhry V, et al. Clinical comparison of muscle specific tyrosine kinase (MuSK) antibody-positive and negative myasthenic patients. Muscle Nerve 2004; 30: 55-60.
19. Nemoto Y, Kuwabara S, Misawa S, et al. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Pshychiatry 2005; 76: 714-718.
20. Ohta K, Shigemoto K, Fujinami A, et al. Clinical and experimental features of MuSK antibody positive MG in Japan. Eur J Neurol 2007; 14: 1029-1034.
21. Shiraishi H, Motomura M, Yoshimura T, et al. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 2005; 57: 289-293.
22. Leite MI, Ströbel P, Jones M, et al. Fewer thymic changes in MuSK antibody-positive MG than in MuSK antibody-negative MG. Ann Neurol 2005; 57: 444-448.
23. Masuda T, Motomura M, Utsugisawa K, et al. Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis. J Neurol Neurosurg Psychiatry 2012; 83: 935-940.
24. Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000; 55: 16-23.
25. Matthews I, Chen S, Hewer R, et al. Muscle-specific receptor tyrosine kinase autoantibodies; a new immunoprecipitation assay. Clin Chim Acta 2004; 348: 95-99.
26. Lindstrom JM, Seybold ME, Lennon VA, et al. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976; 26: 1054-1059.
27. Lübke E, Freiburg A, Skeie GO, et al. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes. J Neuroimmunol 1998; 81: 98-108.
28. Saka E, Topcuoglu MA, Akkaya B, et al. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 2005; 65: 782-783.
29. Lauriola L, Ranelleti F, Maggiano N, et al. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 2005; 64: 536-538.
30. Granzier H, Labeit S. Structure-function relations of the giant elastic protein titin in striated and smooth muscle cells. Muscle Nerve 2007; 36: 740-755.
31. Aarli JA, Stefansson K, Marton LS, et al. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 1990; 82: 284-288.
32. Voltz RD, Albrich WC, Nagele A, et al. Paraneoplastic myasthenia gravis: detection of anti-MGT 30 (titin) antibodies predicts thymic epithelial tumor. Neurology 1997; 49: 1454-1457.
33. Skeie GO, Mygland A, Aarli JA, et al. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity 1995; 20: 99-104.
34. Lanska DJ. Diagnosis of thymoma in myasthenics using anti-striated muscle antibodies: predictive value and gain in diagnostic certainty. Neurology 1991; 41: 520-524.
35. Yamamoto AM, Gajdos P, Eymard B. Anti-titin antibodies in myasthenia gravis; tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol 2001; 58: 885-890.
36. Yagi K. MG and associated diseases. Clin Neurosci 2005; 23: 408-409.
37. Takamori M. Myasthenia gravis epidemiological survey report 1987 Japan, the Health and Labour Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases). 1988;227-245.
38. Monden Y, Uyama T, Nakahara K, et al. Clinical characteristics and prognosis of myasthenia gravis with other autoimmune diseases. Ann Thorac Surg 1986; 41: 189-192.
39. Kanazawa M, Shimohata T, Tanaka K, et al. Clinical features of patients with myasthenia gravis associated with autoimmune diseases. Eur J Neurol 2007; 14: 1403-1404.
40. Leite MI, Coutinho E, Lana-Peixoto M, et al. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 2012; 78: 1601-1607.
41. Yamanaka K, Nakayama H, Watanabe K, et al. Anterior mediastinal mass in a patient with Graves' disease. Ann Thorac Surg 2006; 81: 1904-1906.
42. Tsuda E, Imai T, Matsumura A, et al. Thyrotoxic myopathy mimicking myasthenic syndrome associated with thymic hyperplasia. Inter Med 2008; 47: 445-447.
43. Popoveniuc G, Sharma M, Devdhar M, et al. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function. Thyroid 2010; 20: 1015-1018.